AKR1A1 expression increases following radiation of laryngeal cancer, thereby inhibiting the activation of p53; thus, AKR1A1 plays a role in acquired radiation resistance in laryngeal cancer cells [54]. The gene discussed is AKR1A1; the disease is laryngeal carcinoma.